Tektrotyd (mtck-1)

DESCRIPTION

Active Substance: Vial I contains 20 micrograms of HYNIC- [D-Phe1,Tyr3-Octreotide] trifluoroacetate.

Tektrotyd is for diagnostic use only.

After radiolabelling with sodium pertechnetate (99mTc) solution, the solution of 99mTc-Tektrotyd obtained is indicated for use in adults as adjunct in the diagnosis and management of somatostatin receptor bearing neuroendocrine tumours (NET), by aiding their localization.

Tumours which do not bear somatostatin receptors will not be visualised

For more specific information regarding Tektrotyd, such as the dosage and pharmacological properties, please refer to the SmPC in your region:

Denmark (DK R 55834) -  SmPC in DK

Sweden (528540) -  SmPC in SE   

Finland (33343) - SmPC in FI  

Norway (15-10662) - SmPC in NO